NanoViricides Inc. | Ownership
Companies that own NanoViricides Inc.
The Vanguard Group, Inc.
1,226,306
1.78%
-9,695
0%
06/30/2018
Renaissance Technologies LLC
888,372
1.29%
356,872
0%
06/30/2018
Cowen Investment Management LLC
373,750
0.54%
373,750
0.07%
06/30/2018
Wharton Business Group LLC
363,513
0.53%
0
0.02%
06/30/2018
DWS Investment GmbH
227,676
0.33%
227,672
0%
06/30/2018
Geode Capital Management LLC
175,983
0.26%
0
0%
06/30/2018
Northern Trust Investments, Inc.
106,320
0.15%
0
0%
06/30/2018
Pioneer Trust Bank, NA
100,000
0.14%
0
0.02%
06/30/2018
Raymond James & Associates, Inc. (Invt Mgmt)
60,572
0.09%
572
0%
06/30/2018
Staley Capital Advisers, Inc.
60,000
0.09%
0
0%
06/30/2018
| Address |
1 Controls Drive
Shelton Connecticut 06484
United States
|
|
Employees
|
- |
| Website |
http://www.nanoviricides.com |
| Updated |
07/08/2019 |
| NanoViricides, Inc. is a nano-biopharmaceutical company. The company engages in the discovery, development, and commercialization of therapeutics to advance the care of patients suffering from life-threatening viral infections. It intends to manufacture Injectable and Oral FluCide, HIVCide, Nanoviricide Eye Drops, HerpeCide, DengueCide, RabiCide as well as other drugs for pre-clinical animal studies and human clinical studies. |
